Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1995 Nov;85(11):1488–1489. doi: 10.2105/ajph.85.11.1488

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. J., O'Brien T. R., Politch J. A., Martinez A., Seage G. R., 3rd, Padian N., Horsburgh C. R., Jr, Mayer K. H. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA. 1992 May 27;267(20):2769–2774. [PubMed] [Google Scholar]
  2. Bowler S., Sheon A. R., D'Angelo L. J., Vermund S. H. HIV and AIDS among adolescents in the United States: increasing risk in the 1990s. J Adolesc. 1992 Dec;15(4):345–371. doi: 10.1016/0140-1971(92)90069-h. [DOI] [PubMed] [Google Scholar]
  3. Catania J. A., Binson D., Dolcini M. M., Stall R., Choi K. H., Pollack L. M., Hudes E. S., Canchola J., Phillips K., Moskowitz J. T. Risk factors for HIV and other sexually transmitted diseases and prevention practices among US heterosexual adults: changes from 1990 to 1992. Am J Public Health. 1995 Nov;85(11):1492–1499. doi: 10.2105/ajph.85.11.1492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Grosskurth H., Mosha F., Todd J., Mwijarubi E., Klokke A., Senkoro K., Mayaud P., Changalucha J., Nicoll A., ka-Gina G. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995 Aug 26;346(8974):530–536. doi: 10.1016/s0140-6736(95)91380-7. [DOI] [PubMed] [Google Scholar]
  5. Grund J. P., Stern L. S., Kaplan C. D., Adriaans N. F., Drucker E. Drug use contexts and HIV-consequences: the effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. Br J Addict. 1992 Mar;87(3):381–392. doi: 10.1111/j.1360-0443.1992.tb01939.x. [DOI] [PubMed] [Google Scholar]
  6. Hanenberg R. S., Rojanapithayakorn W., Kunasol P., Sokal D. C. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet. 1994 Jul 23;344(8917):243–245. doi: 10.1016/s0140-6736(94)93004-x. [DOI] [PubMed] [Google Scholar]
  7. Heimer R., Kaplan E. H., Khoshnood K., Jariwala B., Cadman E. C. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med. 1993 Aug;95(2):214–220. doi: 10.1016/0002-9343(93)90263-o. [DOI] [PubMed] [Google Scholar]
  8. Hein K. "Getting real" about HIV in adolescents. Am J Public Health. 1993 Apr;83(4):492–494. doi: 10.2105/ajph.83.4.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hitchcock P. J., Wasserheit J. N., Harris J. R., Holmes K. K. Sexually transmitted diseases in the AIDS era. Development of STD diagnostics for resource-limited settings is a global priority. Sex Transm Dis. 1991 Apr-Jun;18(2):133–135. [PubMed] [Google Scholar]
  10. Hoth D. F., Bolognesi D. P., Corey L., Vermund S. H. NIH conference. HIV vaccine development: a progress report. Ann Intern Med. 1994 Oct 15;121(8):603–611. doi: 10.7326/0003-4819-121-8-199410150-00008. [DOI] [PubMed] [Google Scholar]
  11. Ickovics J. R., Morrill A. C., Beren S. E., Walsh U., Rodin J. Limited effects of HIV counseling and testing for women. A prospective study of behavioral and psychological consequences. JAMA. 1994 Aug 10;272(6):443–448. [PubMed] [Google Scholar]
  12. Kelly J. A., St Lawrence J. S., Betts R., Brasfield T. L., Hood H. V. A skills-training group intervention model to assist persons in reducing risk behaviors for HIV infection. AIDS Educ Prev. 1990 Spring;2(1):24–35. [PubMed] [Google Scholar]
  13. Laga M., Alary M., Nzila N., Manoka A. T., Tuliza M., Behets F., Goeman J., St Louis M., Piot P. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet. 1994 Jul 23;344(8917):246–248. doi: 10.1016/s0140-6736(94)93005-8. [DOI] [PubMed] [Google Scholar]
  14. Levin L. I., Peterman T. A., Renzullo P. O., Lasley-Bibbs V., Shu X. O., Brundage J. F., McNeil J. G. HIV-1 seroconversion and risk behaviors among young men in the US army. The Seroconversion Risk Factor Study Group. Am J Public Health. 1995 Nov;85(11):1500–1506. doi: 10.2105/ajph.85.11.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Oakley A., Fullerton D., Holland J. Behavioural interventions for HIV/AIDS prevention. AIDS. 1995 May;9(5):479–486. [PubMed] [Google Scholar]
  16. Rotheram-Borus M. J., Koopman C., Haignere C., Davies M. Reducing HIV sexual risk behaviors among runaway adolescents. JAMA. 1991 Sep 4;266(9):1237–1241. [PubMed] [Google Scholar]
  17. Rouse D. J., Owen J., Goldenberg R. L., Vermund S. H. Zidovudine for the prevention of vertical HIV transmission: a decision analytic approach. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):401–407. [PubMed] [Google Scholar]
  18. Stein Z. HIV prevention: an update on the status of methods women can use. Am J Public Health. 1993 Oct;83(10):1379–1382. doi: 10.2105/ajph.83.10.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Vermund S. H. The role of prevention research in HIV vaccine trials. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S303–S305. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES